VilactoBio™ Game Plan

Our core strategy is to leverage biopharmaceutical expertise, LACTOACTIVE iTHER® technology and patents to develop an innovative drug discovery approach. This helps identify, develop and explore new industries, and improve on the products and services in existing industries, using our patented prototypes.

Also, our research efforts concentrate on using our patent rights, including the development of drug design and pharmaceutical formulation, to drug-target interactions with considering comparable efficacy and fewer pharmacovigilance issues.

As per our patent documents, we are planning cooperation with different fields of medical science such as biopharmaceutics, Nano pharmacology, biotechnology, immunology, dermatology, oncology, rheumatology, neurology and more. This presents the possibility of designing new therapeutic medication for serious diseases including cancer, diabetes, rheumatism, hemophilia and more.

We plan to promote our technology aggressively, drawing on proven sales, research, and production techniques. Our sales strategy includes licensing patented ingredients to third-party companies for use in their own products.